Subscribe To

Price Alert Latest News Economic Calendar News

CMPS / COMPASS Pathways plc (CMPS) Q3 2023 Earnings Call Transcript

COMPASS Pathways plc (NASDAQ:CMPS ) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Mary-Rose Hughes - Interim CFO Dr. Guy Goodwin - Chief Medical Officer Conference Call Participants Ritu Baral - TD Cohen Charles Duncan - Cantor François Brisebois - Oppenheimer Patrick Trucchio - H.C. Wainright Michael Okunewitch - Maxim Group Sumant Kulkarni - Canaccord Genuity Gavin Clark-Gartner - Evercore ISI Thomas Shrader - BTIG Operator Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Third Quarter 2023 Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Compass

Pathways

CMPS

2023

Earnings

Call

Transcript

cmps

Stock

Posted: Nov 4 2023, 11:51

Author Name: Seeking Alpha

CMPS News

By Seeking Alpha
November 4, 2023

COMPASS Pathways plc (CMPS) Q3 2023 Earnings Call Transcript

COMPASS Pathways plc (NASDAQ:CMPS ) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir N

By GlobeNewsWire
October 24, 2023

COMPASS Pathways plc to Announce Third Quarter 2023 Financial Results on November 2, 2023

LONDON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evi

By InvestorPlace
September 27, 2023

Don't Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher

Psychedelic stocks are on the rise. Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their useful

By GlobeNewsWire
August 29, 2023

COMPASS Pathways to participate in upcoming September investor conferences

LONDON, Aug. 29, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evi

By Seeking Alpha
August 5, 2023

COMPASS Pathways plc (CMPS) Q2 2023 Earnings Call Transcript

COMPASS Pathways plc (NASDAQ:CMPS ) Q2 2023 Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Stephen Schultz - Senior Vice Pres

By GlobeNewsWire
July 31, 2023

COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

LONDON, July 31, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evi

By The Motley Fool
July 28, 2023

This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock

COMP360 appears to be compatible with certain antidepressant medications. That's contrary to some prior assumptions, so it's a pleasant surprise.

By The Motley Fool
July 1, 2023

Can Compass Pathways' Stock Gain 458% Like Wall Street Is Expecting?

Analysts are expecting Compass Pathways' stock to blast off soon. There aren't actually any expected near-term events which might drive such a rise.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.